Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences’ SARS-CoV-2 Multiplex Amplicon Sequencing Panel

Amin Addetia, Michelle J. Lin, Vikas Peddu, Pavitra Roychoudhury, Keith R. Jerome, Alexander L. Greninger
John P. Dekker, Editor
Amin Addetia
aDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle J. Lin
aDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vikas Peddu
aDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pavitra Roychoudhury
aDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
bVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith R. Jerome
aDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
bVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander L. Greninger
aDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
bVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander L. Greninger
John P. Dekker
National Institute of Allergy and Infectious Diseases
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.02226-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

Whole-genome sequencing (WGS) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a better understanding of the virus’s origin, transmission, and evolution (1–6). Multiplex amplicon sequencing for viral WGS is a preferred approach to library preparation since it is simple, sensitive, cost-effective, and scalable (7, 8). However, balancing multiplexed primers to achieve high sensitivity and even coverage can be difficult (8), and superlative analytical sensitivity is not assured. Here, we evaluated the Swift Biosciences’ single-tube SARS-CoV-2 multiplex amplicon sequencing panel for the recovery of genomes from low-viral-load samples (threshold cycle [CT] > 26 on a Hologic Panther Fusion system).

This work was approved by the University of Washington Institutional Review Board (proposal no. STUDY00000408). Libraries were constructed from double-stranded cDNA using Swift Biosciences’ Normalase amplicon SARS-CoV-2 panel. The resulting libraries were sequenced on 2× 300-bp MiSeq runs, and a median of 605,654 reads were obtained for each library. Genomes were assembled with a custom pipeline, TAYLOR (https://github.com/greninger-lab/covid_swift_pipeline). Briefly, sequence reads were trimmed using Trimmomatic v0.38, aligned to the Wuhan-Hu-1 genome (NCBI accession no. NC_045512.2) using BBMap v38.70 (https://sourceforge.net/projects/bbmap/), and trimmed of PCR primers using Primerclip (https://github.com/swiftbiosciences/primerclip). Consensus genomes were called bcftools v1.9.

The 61 samples sequenced had CT values ranging from 26.04 to 37.93. We recovered genomes from all samples with a CT of ≤32.16 and from a sample with a CT value of 36.77, equivalent to approximately 4.24 copies input (Fig. 1A) (9–11). For samples with a CT value between 32.01 and 34.00, we recovered genomes from 8/10 (80%) of the samples, and for samples with a CT value between 34.01 and 36.00, we recovered genomes from 4/10 (40%) of the samples. While we recovered genomes from just 3 of the samples with a CT value between 36.01 and 38.00, we were able to recover partial genomes for the other 7 samples (median genome covered, 36.0%; range, 4.9 to 73.7%).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Evaluation of the Swift Biosciences’ SARS-CoV-2 multiplex amplicon sequencing panel. (A) Complete genomes were recovered from all samples with a CT value of ≤32.16 and a CT value as high as 36.77. Samples for which complete genomes (>95% genome coverage) were recovered are highlighted in purple. Partial genomes are highlighted in gold. (B) SARS-CoV-2 sequences were highly enriched in the sequencing libraries as measured by the percentage of reads mapping to the reference genome for SARS-CoV-2 (NCBI accession no. NC_045512.2). Complete genomes were recovered for samples highlighted in purple, while partial genomes were recovered for those highlighted in gold. (C) The genome coverage between nucleotides 201 and 29741 of the SARS-CoV-2 reference genome is even. The 5th and 95th percentiles of coverage at each position across the 41 samples with a mean depth of >100× are plotted in purple. A 250-nucleotide window moving average is represented in gold. (D) The 46 SARS-CoV-2 samples with complete genomes belong to both major SARS-CoV-2 lineages. A phylogenetic tree with the 46 SARS-CoV-2 genomes recovered in this report and 109 other global strains was constructed with FastTree version 2.1.1. Strains belonging to lineage A are highlighted in purple, while those belonging to lineage B are highlighted in gold. Those genomes sequenced in this report are circled in black. SNV, single nucleotide variation.

The libraries produced with the Swift SARS-CoV-2 amplicon panel were highly enriched for SARS-CoV-2 reads. Samples with CT values ranging from 26.01 to 32.00 had a median on-target percentage of 98.5% (range, 93.1 to 99.0%) after removal of reads attributed to primer dimer formation (Fig. 1B). Among samples with CT values from 32.01 to 38.00, the median on-target percentage was 92.4% (range, 16.5 to 98.7) (Fig. 1B).

We also assessed the coverage distribution from samples with an average depth of >100×. The coverage across the genome for the 41 samples analyzed was highly even (Pielou’s evenness, 0.988) (Fig. 1C). To assess reproducibility, we performed 8 separate library preparations on a single sample. All 8 preparations yielded identical consensus sequences, demonstrating the high reproducibility of the Swift SARS-CoV-2 amplicon panel.

Lastly, we performed a phylogenetic analysis of the 46 strains with complete genomes and 109 randomly selected global SARS-CoV-2 strains. The 46 strains belonged to both major lineages defined by pangolin (https://github.com/cov-lineages/pangolin) (12) and reflected the genomic diversity currently circulating in the SARS-CoV-2 population (Fig. 1D).

In summary, the Swift SARS-CoV-2 amplicon panel is a simple, highly sensitive approach for recovering SARS-CoV-2 genomes. The panel has allowed for the study of genomic rearrangements and mutations that are uniquely associated with low-viral-load samples (13, 14).

Data availability.Sequencing data are available under NCBI BioProject no. PRJNA610428 (Table 1). Code for assembling consensus FASTA genomes from FASTQ files is also available online (https://github.com/greninger-lab/covid_swift_pipeline).

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1

Assembly and sequencing read accession numbers for strains sequenced in this studya

ACKNOWLEDGMENT

Swift Biosciences provided reagent for optimization of this protocol but had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

FOOTNOTES

    • Accepted manuscript posted online 12 October 2020.
  • Supplemental material is available online only.

  • Copyright © 2020 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Andersen KG,
    2. Rambaut A,
    3. Lipkin WI,
    4. Holmes EC,
    5. Garry RF
    . 2020. The proximal origin of SARS-CoV-2. Nat Med 26:450–452. doi:10.1038/s41591-020-0820-9.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Deng X,
    2. Gu W,
    3. Federman S,
    4. Du Plessis L,
    5. Pybus OG,
    6. Faria NR,
    7. Wang C,
    8. Yu G,
    9. Bushnell B,
    10. Pan C-Y,
    11. Guevara H,
    12. Sotomayor-Gonzalez A,
    13. Zorn K,
    14. Gopez A,
    15. Servellita V,
    16. Hsu E,
    17. Miller S,
    18. Bedford T,
    19. Greninger AL,
    20. Roychoudhury P,
    21. Starita LM,
    22. Famulare M,
    23. Chu HY,
    24. Shendure J,
    25. Jerome KR,
    26. Anderson C,
    27. Gangavarapu K,
    28. Zeller M,
    29. Spencer E,
    30. Andersen KG,
    31. MacCannell D,
    32. Paden CR,
    33. Li Y,
    34. Zhang J,
    35. Tong S,
    36. Armstrong G,
    37. Morrow S,
    38. Willis M,
    39. Matyas BT,
    40. Mase S,
    41. Kasirye O,
    42. Park M,
    43. Masinde G,
    44. Chan C,
    45. Yu AT,
    46. Chai SJ,
    47. Villarino E,
    48. Bonin B,
    49. Wadford DA,
    50. Chiu CY
    . 2020. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. Science 369:582–587. doi:10.1126/science.abb9263.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Fauver JR,
    2. Petrone ME,
    3. Hodcroft EB,
    4. Shioda K,
    5. Ehrlich HY,
    6. Watts AG,
    7. Vogels CBF,
    8. Brito AF,
    9. Alpert T,
    10. Muyombwe A,
    11. Razeq J,
    12. Downing R,
    13. Cheemarla NR,
    14. Wyllie AL,
    15. Kalinich CC,
    16. Ott IM,
    17. Quick J,
    18. Loman NJ,
    19. Neugebauer KM,
    20. Greninger AL,
    21. Jerome KR,
    22. Roychoudhury P,
    23. Xie H,
    24. Shrestha L,
    25. Huang M-L,
    26. Pitzer VE,
    27. Iwasaki A,
    28. Omer SB,
    29. Khan K,
    30. Bogoch II,
    31. Martinello RA,
    32. Foxman EF,
    33. Landry ML,
    34. Neher RA,
    35. Ko AI,
    36. Grubaugh ND
    . 2020. Coast-to-coast spread of SARS-CoV-2 during the early epidemic in the United States. Cell 181:990–996.E5. doi:10.1016/j.cell.2020.04.021.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Tang X,
    2. Wu C,
    3. Li X,
    4. Song Y,
    5. Yao X,
    6. Wu X,
    7. Duan Y,
    8. Zhang H,
    9. Wang Y,
    10. Qian Z,
    11. Cui J,
    12. Lu J
    . 2020. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev 7:1012–1023. doi:10.1093/nsr/nwaa036.
    OpenUrlCrossRef
  5. 5.↵
    1. Korber B,
    2. Fischer WM,
    3. Gnanakaran S,
    4. Yoon H,
    5. Theiler J,
    6. Abfalterer W,
    7. Hengartner N,
    8. Giorgi EE,
    9. Bhattacharya T,
    10. Foley B,
    11. Hastie KM,
    12. Parker MD,
    13. Partridge DG,
    14. Evans CM,
    15. Freeman TM,
    16. de Silva TI,
    17. McDanal C,
    18. Perez LG,
    19. Tang H,
    20. Moon-Walker A,
    21. Whelan SP,
    22. LaBranche CC,
    23. Saphire EO,
    24. Montefiori DC,
    25. Angyal A,
    26. Brown RL,
    27. Carrilero L,
    28. Green LR,
    29. Groves DC,
    30. Johnson KJ,
    31. Keeley AJ,
    32. Lindsey BB,
    33. Parsons PJ,
    34. Raza M,
    35. Rowland-Jones S,
    36. Smith N,
    37. Tucker RM,
    38. Wang D,
    39. Wyles MD
    . 2020. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182:812–827.E19. doi:10.1016/j.cell.2020.06.043.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Bedford T,
    2. Greninger AL,
    3. Roychoudhury P,
    4. Starita LM,
    5. Famulare M,
    6. Huang M-L,
    7. Nalla A,
    8. Pepper G,
    9. Reinhardt A,
    10. Xie H,
    11. Shrestha L,
    12. Nguyen TN,
    13. Adler A,
    14. Brandstetter E,
    15. Cho S,
    16. Giroux D,
    17. Han PD,
    18. Fay K,
    19. Frazar CD,
    20. Ilcisin M,
    21. Lacombe K,
    22. Lee J,
    23. Kiavand A,
    24. Richardson M,
    25. Sibley TR,
    26. Truong M,
    27. Wolf CR,
    28. Nickerson DA,
    29. Rieder MJ,
    30. Englund JA,
    31. Hadfield J,
    32. Hodcroft EB,
    33. Huddleston J,
    34. Moncla LH,
    35. Müller NF,
    36. Neher RA,
    37. Deng X,
    38. Gu W,
    39. Federman S,
    40. Chiu C,
    41. Duchin JS,
    42. Gautom R,
    43. Melly G,
    44. Hiatt B,
    45. Dykema P,
    46. Lindquist S,
    47. Queen K,
    48. Tao Y,
    49. Uehara A,
    50. Tong S,
    51. MacCannell D,
    52. Armstrong GL
    , Seattle Flu Study Investigators, et al. 2020. Cryptic transmission of SARS-CoV-2 in Washington state. Science. doi:10.1126/science.abc0523.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Tyson JR,
    2. James P,
    3. Stoddart D,
    4. Sparks N,
    5. Wickenhagen A,
    6. Hall G,
    7. Choi JH,
    8. Lapointe H,
    9. Kamelian K,
    10. Smith AD,
    11. Prystajecky N,
    12. Goodfellow I,
    13. Wilson SJ,
    14. Harrigan R,
    15. Snutch TP,
    16. Loman NJ,
    17. Quick J
    . 2020. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv https://doi.org/10.1101/2020.09.04.283077.
  8. 8.↵
    1. Itokawa K,
    2. Sekizuka T,
    3. Hashino M,
    4. Tanaka R,
    5. Kuroda M
    . 2020. Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR. PLoS One 15:e0239403. doi:10.1371/journal.pone.0239403.
    OpenUrlCrossRef
  9. 9.↵
    1. Lieberman JA,
    2. Pepper G,
    3. Naccache SN,
    4. Huang M-L,
    5. Jerome KR,
    6. Greninger AL
    . 2020. Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol 58:e00821-20. doi:10.1128/JCM.00821-20.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Nalla AK,
    2. Casto AM,
    3. Huang M-LW,
    4. Perchetti GA,
    5. Sampoleo R,
    6. Shrestha L,
    7. Wei Y,
    8. Zhu H,
    9. Jerome KR,
    10. Greninger AL
    . 2020. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J Clin Microbiol 58:e00557-20. doi:10.1128/JCM.00557-20.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Perchetti GA,
    2. Nalla AK,
    3. Huang M-L,
    4. Zhu H,
    5. Wei Y,
    6. Stensland L,
    7. Loprieno MA,
    8. Jerome KR,
    9. Greninger AL
    . 2020. Validation of SARS-CoV-2 detection across multiple specimen types. J Clin Virol 128:104438. doi:10.1016/j.jcv.2020.104438.
    OpenUrlCrossRef
  12. 12.↵
    1. Rambaut A,
    2. Holmes EC,
    3. O’Toole Á,
    4. Hill V,
    5. McCrone JT,
    6. Ruis C,
    7. Du Plessis L,
    8. Pybus OG
    . 15 July 2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol doi:10.1038/s41564-020-0770-5.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Addetia A,
    2. Xie H,
    3. Roychoudhury P,
    4. Shrestha L,
    5. Loprieno M,
    6. Huang M-L,
    7. Jerome KR,
    8. Greninger AL
    . 2020. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates. J Clin Virol 129:104523. doi:10.1016/j.jcv.2020.104523.
    OpenUrlCrossRef
  14. 14.↵
    1. Addetia A,
    2. Lieberman NAP,
    3. Phung Q,
    4. Xie H,
    5. Roychoudhury P,
    6. Shrestha L,
    7. Loprieno M,
    8. Huang M-L,
    9. Jerome KR,
    10. Greninger AL
    . 2020. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic transport through interactions with Rae1 and Nup98. bioRxiv https://www.biorxiv.org/content/10.1101/2020.08.03.234559v1.full.
PreviousNext
Back to top
Download PDF
Citation Tools
Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences’ SARS-CoV-2 Multiplex Amplicon Sequencing Panel
Amin Addetia, Michelle J. Lin, Vikas Peddu, Pavitra Roychoudhury, Keith R. Jerome, Alexander L. Greninger
Journal of Clinical Microbiology Dec 2020, 59 (1) e02226-20; DOI: 10.1128/JCM.02226-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences’ SARS-CoV-2 Multiplex Amplicon Sequencing Panel
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences’ SARS-CoV-2 Multiplex Amplicon Sequencing Panel
Amin Addetia, Michelle J. Lin, Vikas Peddu, Pavitra Roychoudhury, Keith R. Jerome, Alexander L. Greninger
Journal of Clinical Microbiology Dec 2020, 59 (1) e02226-20; DOI: 10.1128/JCM.02226-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

SARS-CoV-2
amplicon panel
genome
genome recovery

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X